Oncology Clinical Trials in New Orleans, LA
As of August 2026, 69 paid clinical trials are recruiting for Oncology in New Orleans, Louisiana. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
69 clinical trials for Oncology
·Clear filters·A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Galleri® in the Medicare Population.
Caris Biorepository Research Protocol
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs
Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier
DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
Study to Evaluate IMGS-001 Treatment in Patients With Relapsed or Refractory Advanced Solid Tumors
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK201 in Participants With Advanced Solid Tumors
A Study of Lorigerlimab in Participants With Advanced Solid Tumors
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
E-Mindfulness Approaches for Living After Breast Cancer
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Top Research Study Locations in New Orleans
Researchers run research studies in New Orleans, LA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University Medical Center New Orleans | Anatomic Stage II Breast Cancer AJCC v8, Heart Failure, Malignant Solid Neoplasm | 48 |
| Ochsner Medical Center Jefferson | Advanced Malignant Solid Neoplasm, B Acute Lymphoblastic Leukemia, Malignant Solid Neoplasm | 45 |
| Ochsner Clinic Foundation | Neoplasm Metastasis, Acute Stroke, Chronic Low-back Pain | 35 |
| Children's Hospital New Orleans | Malignant Solid Neoplasm, B Acute Lymphoblastic Leukemia, Ganglioneuroblastoma, Nodular | 28 |
| Louisiana State University Health Science Center | Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Anatomic Stage I Breast Cancer AJCC v8 | 17 |
| Tulane University | Ulcerative Colitis, Aneurysm, Brain, Anxiety | 16 |
| DelRicht Research | Chronic Pain, Osteoarthritis, Knee, Acute Gout Flare | 12 |
| Ochsner Medical Center | Aortic Valve Disease, Aortic Valve Stenosis, Hypertension | 10 |
| Tulane University School of Medicine | Von Willebrand Disease (VWD), Von Willebrand Disease (VWD), Type 1, Von Willebrand Disease (VWD), Type 2 | 10 |
| University Medical Center | Atrial Fibrillation, Hidradenitis Suppurativa, Abdominal Wound Dehiscence | 10 |
| Touro Infirmary | Anatomic Stage II Breast Cancer AJCC v8, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | 9 |
| Louisiana State University Health Sciences Center | Aortoiliac Occlusive Disease, Breast Cancer, Dacryocystitis | 8 |
| Louisiana State University | Aortic Stenosis, Calcific, Aortic Valve Stenosis, Articular Fractures | 7 |
| East Jefferson General Hospital | Atrial Fibrillation, Atrial Arrhythmia, Atrial Flutter | 6 |
| Ochsner Baptist Medical Center | Abdominal Wound Dehiscence, Anal Fistula, Endometrial Carcinoma | 6 |
| Ochsner Health | Advanced Solid Tumor, Age-related Macular Degeneration (AMD), Coronary Arterial Disease (CAD) | 6 |
| Tulane University Medical Center | Acute Kidney Injury, Covid19, Droopy Eyelid | 5 |
| The Policy & Research Group | Teen Pregnancy Prevention | 4 |
| Ochsner Health System | Cardiovascular Diseases, Eustachian Tube Dysfunction, Functional Mitral Regurgitation | 3 |
| Southeast Louisiana Veterans Health Care System, New Orleans, LA | Secure Firearm Storage, Suicidal Ideation, Suicide | 3 |
| Tulane Cancer Center | Bladder Carcinoma, Cutaneous Melanoma, Endometrial Carcinoma | 3 |
| Tulane Doctors - Speciality Care - Napoleon | Atrial Fibrillation, Cardiomyopathies, Obstructive Sleep Apnea | 3 |
| Tulane Medical Center | Community-acquired Pneumonia, Influenza, COVID-19, Interstitial Lung Disease, Kidney Transplant Rejection | 3 |
| University Medical Center - New Orleans | Advanced or Metastatic Castration-Resistant Prostate Cancer (mCRPC), Advanced or Metastatic ER+ HER2- Breast Cancer (mBC), Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) | 3 |
| DelRicht Research - LCMC Health Urgent Care - Lakeview | Gout, Tophaceous Gout | 2 |
Active & Upcoming Studies in New Orleans (2026)
Recruiting trials in New Orleans grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (110 active studies)
- Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer · Phase 2 · National Cancer Institute (NCI)
- A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer · Phase 3 · J-Pharma Co., Ltd.
Cardiovascular (41 active studies)
- A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF · Phase 3 · AstraZeneca
- The RESPLASH Study · Tulane University
Neurology & pain (33 active studies)
- A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Chronic Low Back Pain · Phase 2 · Eli Lilly and Company
- A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
Diabetes & metabolic (11 active studies)
- Periodontal Inflammation and Epigenetics in Obese Individuals · Louisiana State University Health Sciences Center in New Orleans
- A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes · Phase 3 · Hoffmann-La Roche
HIV / STI (10 active studies)
- Are Louisiana Pharmacists PrEPared? Implementing Training and an Active PrEP (Pre-Exposure Prophylaxis) Prescribing Surveillance Program · Xavier University of Louisiana.
- Combatting HIV Or Other STIs Early (CHOOSE) · Phase 2 · Westat
Mental health & behavior (7 active studies)
- A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD) · Phase 2 · Tonix Pharmaceuticals, Inc.
- Improving Health Literacy in Patients With Schizophrenia Spectrum Disorder · Louisiana State University Health Sciences Center in New Orleans
Vaccines (4 active studies)
- A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose · Phase 3 · Pfizer
- Intervention to Prevent Behavioral Health Symptoms Among Pandemic Affected Children · University of Illinois at Urbana-Champaign
Eye & vision (3 active studies)
- The Effect of Lumify™ on Ocular Redness, Intraocular Pressure, and Eyelid Position in Glaucoma Patients · Phase 4 · Tulane University
- A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma · Phase 3 · AbbVie
Pediatric (3 active studies)
- Multicenter HomeVENT: Home Values and Experiences Navigation Track · Johns Hopkins University
- Supportive Hospital-Based Intervention for Firearm Trauma · Tulane University
Common conditions studied in New Orleans
- Atrial Fibrillation (8 active studies)
- Malignant Solid Neoplasm (7 active studies)
- Hypertension (6 active studies)
- Breast Cancer (5 active studies)
- Cardiovascular Diseases (5 active studies)
- Heart Failure (5 active studies)
Leading research sponsors in New Orleans
- National Cancer Institute (NCI)
- Tulane University
- Children's Oncology Group
- Eli Lilly and Company
- NRG Oncology
Frequently asked questions
How many paid clinical trials are currently recruiting in New Orleans?
There are approximately 395 recruiting clinical trials in New Orleans, Louisiana listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in New Orleans pay participants?
Most recruiting trials in New Orleans compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in New Orleans?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in New Orleans?
The most common conditions under active study in New Orleans include Atrial Fibrillation (8), Malignant Solid Neoplasm (7), Hypertension (6), Breast Cancer (5), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in New Orleans?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in New Orleans on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in New Orleans?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in New Orleans?
Recruiting research sites in New Orleans include University Medical Center New Orleans, Ochsner Medical Center Jefferson, Ochsner Clinic Foundation, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in New Orleans right now?
The largest active categories in New Orleans are Cancer & tumors (110), Cardiovascular (41), Neurology & pain (33). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.